Ambler Clinic in Ambler, AK - Clinic/Center

Ambler Clinic is a primary clinic (Clinic/center) in Ambler, Alaska. The current practice location for Ambler Clinic is 110 Main St, Ambler, Alaska. For appointments, you can reach them via phone at (907) 442-3321. The mailing address for Ambler Clinic is Po Box 43, Kotzebue, Alaska and phone number is (907) 442-3321.

Ambler Clinic is licensed to practice in * (Not Available) (license number ) and its NPI number is 1730835240. This medical practice does not participate in medicare program and thus may not accept your medicare insurance. You may check if they accept your insurance at (907) 442-3321.

Contact Information

	Ambler Clinic
	110 Main St Ambler AK 99786
	(907) 442-3321
	(907) 442-7250

Primary Care Clinic Profile

Full Name	Ambler Clinic
Speciality	Clinic/center
Location	110 Main St, Ambler, Alaska
Authorized Official Name and Position	Gus Nelson (PROVIDER ENROLLMENT SPECIALIST)
Authorized Official Contact	9074423321
Accepts Medicare Insurance	This clinic does not participate in Medicare Program.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Ambler Clinic Po Box 43 Kotzebue AK 99752-0043 Ph: (907) 442-3321	Ambler Clinic 110 Main St Ambler AK 99786 Ph: (907) 442-3321

NPI Details:

NPI Number	1730835240
Provider Enumeration Date	02/23/2022
Last Update Date	03/15/2022

Medical Identifiers

Medical identifiers for Ambler Clinic such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1730835240	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
261Q00000X	Clinic/center	(* (Not Available))	Primary

News Archive

Interim results from Phase 1 CAL-101 trial for chronic lymphocytic leukemia

Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced the presentation of interim results from the ongoing Phase 1 trial evaluating CAL-101, an oral delta-selective PI3K inhibitor, demonstrating promising clinical responses in patients with relapsed or refractory chronic lymphocytic leukemia (CLL).

Matrix honors EP Vantage with European Mediscience 2011 Commentator of the Year award

EP Vantage, part of EvaluatePharma, was presented with the coveted Commentator of the Year Award at the European Mediscience Awards, sponsored by Matrix, on June 22, 2011.

Rapid reopening crucial in promoting the second wave of COVID-19

The spread of the coronavirus disease 2019 (COVID-19) has affected almost a hundred million people, with over two million deaths being attributed to this illness over the past 12 months or so. The only means to counter this so far has been through non-pharmaceutical interventions (NPIs).

Researchers seek to end disparities in cancer, stroke care

HealthDay/U.S. News & World Report: Research has shown that there is a racial gap in breast cancer care, "with black and Hispanic women less likely to get recommended breast cancer treatments than white patients."

Neurocognitive deficits worsen outcomes for joint replacement surgery, finds study

Patients with undiagnosed neurocognitive deficits are more likely to undergo joint replacement surgeries and suffer worse outcomes, finds study.

Clinic/Center in Ambler, AK

Ambler Clinic
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 110 Main Street, Ambler, AK 99786
Phone: 907-445-2129 Fax: 907-445-2179

Ambler Clinic - Primary Care in Ambler, AK